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Abstract: Twenty-eight native plants mainly used to cure diseases related to microbial infection and stress oxidative disorders were selected 
to test the antimicrobial activity against E. coli, P. aeruginosa, S. aureus, B. subtilis, and C. albicans using diffusion and microdilution 
methods. The antioxidant activity was determined by scavenging DPPH free-radical and phytochemical evaluation was performed for plants 
with promising activities. Twenty-seven plants showed antibacterial activity, four had anti-Candida activity, and four showed antioxidant 
activity. It was found that Oreocallis grandiflora, Gentianella weberbaueri, Gamochaeta americana, Hypericum laricifolium, Loricaria 
ferruginea, Muehlenbeckia volcanica, and Oenothera multicaulis, showed promising biological activity and contained alkaloids, phenolic 
compounds, flavonoids, catecholic or gallic tannins. This study leaves evidence about the medicinal potential of wild high-Andean plants; 
thus, further pharmacological, phytochemical, ecological and biotechnological studies will contribute to promote their conservation and 
sustainable use; especially since they are highly vulnerable and risk extinction. 
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Resumen: Se seleccionó veintiocho plantas nativas usadas principalmente para tratarcurar enfermedades relacionadas principalmente con 
infecciones microbianas y desordenes oxidativos. A estas plantas se para ser evaluóados en su actividad antimicrobiana sobre E. coli, P. 
auriginosa, S. aureus, B. subtilis, y C. albicans usando métodos de difusión y microdilución. Se determinó la actividad antioxidante 
mediante el ensayo del libre radical DPPH y se realizó la evaluación fitoquímica de las plantas con actividades promisorias. Veinte siete 
plantas mostraron actividad antibacteriana, cuatro mostraron actividad anti-Candida, y cuatro actividad antioxidante. Oreocallis grandiflora, 
Gentianella weberbaueri, Gamochaeta americana, Hypericum laricifolium, Loricaria ferruginea, Muehlenbeckia volcanica, y Oenothera 
multicaulis mostraron actividad biológica promisoria, y se encontró que contienen alcaloides, compuestos fenólicos, flavonoides, taninos 
gálicos y catecólicos. Este estudio deja evidencia del potencial medicinal de las plantas silvestres alto andinas; por lo tanto, los estudios 
farmacológicos, fitoquímicos, ecológicos y biotecnológicos contribuirían en la promoción de su conservación y uso sustentable debido a su 
alta vulnerabilidad y riesgo de extinción. 
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INTRODUCTION 
Facing an increased demand for new bioactive 
principles to cure new and emergent diseases 
secondary metabolites from plants are being explored 
continuously. Nowadays pathogen microorganisms 
have the ability to develop resistance to conventional 
antibiotics (Abedini et al., 2014; Guil-Guerrero et al., 
2016), therefore, new antimicrobial compounds 
become necessary to fight the prominent microbial 
infections (Aumeeruddy-Elalfi et al., 2016); which can 
be achieved by focusing in plants used in traditional 
medicine (Aumeeruddy-Elalfi et al., 2016; Gupta et al., 
2016; Chander et al., 2016). It seems that plants have 
different mechanisms for microbial growth inhibition 
compared to microbial or synthetic origin antibiotics, 
furthermore it seems that pathogen microorganisms 
do not develop resistance to antimicrobial compounds 
from plants (Abedini et al., 2014).  
Likewise, within the cells oxidative stress 
generates free radicals (ROS) that degrade proteins, 
lipids and DNA (Jayathilake et al. 2016); this damage 
is associated with neurodegenerative and coronary 
diseases, diabetes, atherosclerosis, inflammation, 
digestive system disorders, viral infections, and 
cancer (Tauchen et al., 2016; Al-Jaber et al., 2011; 
Jayathilake et al., 2016). Cells produce antioxidant 
substances for its self-protection, but when this 
activity is low or the oxidative stress increases, it is 
recommended the consumption of antioxidant 
substances commonly provided by food and 
medicinal plants (Jayathilake et al., 2016); usually 
these plant antioxidant metabolites are polyphenols 
(Al-Jaber et al., 2011). 
Therefore, the knowledge of medicinal plants 
as a source of bioactive principles provides great 
opportunities for the development of new medicines 
(Barboza et al., 2009; Rehecho et al., 2011; Chander 
et al., 2016). Ethnopharmacology studies in Andean 
zones report a wide diversity of plants used to treat 
different ailments (Rojas et al., 2003; De-la-Cruz et al., 
2007; Bussmann et. al., 2010; Rehecho et al., 2011; 
Gonzales De La Cruz et al., 2014), including some 
diseases related to microbial infections and oxidative 
stress.  
The Cordillera Blanca in Ancash has a 
representative biodiversity of high-Andean Peruvian 
ecosystems from which wild medicinal plants are 
extracted and marketed. Most of them are herbaceous 
and are collected with roots and flowers generating 
risks of extinction by over exploitation such as 
Muehlenbeckia volcanica, Perezia coerulescens, 
Perezia multiflora, Perezia pinnatifida, Senecio 
canescens, Senecio rhizomatus, Stangea sp. (De-la-
Cruz et al., 2007; Gonzales De La Cruz et al., 2014). 
In addition, the climate change is making the high-
Andean biodiversity conservation problem bigger, 
because it increases the vulnerability and 
irreplaceability of the biodiversity of the high-
Andean ecosystem represented by small populations 
of endemic species (Ramirez-Villegas et al., 2014); 
therefore conservation effort should take place urgently 
in order to protect most vulnerable species (Gonzales De 
la Cruz et al., 2014). Some studies to perform in vitro 
culture techniques to protect these genetic resources 
were described only to Perezia coerulescens (Olivera et 
al., 2010), O. grandiflora (Olivera-Gonzales et al., 
2017a), and P. pinnatifida (Olivera-Gonzales et al., 
2017b); but in this panorama, studies of their 
pharmacological activities, phytochemical composition, 
and even less genetic authentification are not considered 
as a urgent topic to study. 
Hence, this research is focused in medicinal 
wild plants from the Ancash high Andean zone. The 
antimicrobial activity was evaluated against four 
bacteria and one yeast involved in common infections 
illnesses such as respiratory, skin, urinary, stomach, 
etc.. Their antioxidant activity was also screened, and 
phytochemical studies began. The results support 
other studies, which aim to promote biotechnological 
applications for the conservation and sustainable use 
of these threatened plants.  
MATERIALS AND METHODS 
Plant material 
Some wild plants mostly used to treat diseases related 
to microbial infections were selected. Most were 
collected from or around the Huascaran National 
Park located in Cordillera Blanca (Ancash-Peru); and 
a few were bought at popular market from Huaraz. 
Other criteria of selection were vulnerability, risk of 
extinction and/or endemism. The taxonomic 
identification and storage of herbarium specimens 
(samples with flowers) were made at the David Smith 
Herbarium of the Universidad Nacional Santiago 
Antúnez de Mayolo 
Http://grbio.org/institution/uiversidad-nacional-
santiago-antunez-de-mayolo) In addition, little 
piece of dried leaves were stored at -70° C for future 
DNA barcoding preparation.  
 
Plant extracts preparation 
Plant extract preparation was performed according 
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Martin et al. (1965) and Cáceres (1996). The plants 
were washed with tap water and dried under fresh air 
and shade. The dried samples were milled and sieved 
up to 2 mm. After that, they were macerated with 
ethanol 50º (10:90 w/v) under darkness and room 
temperature (18-22° C) for 12 days to attain 
maximum extraction. The samples were filtered on 
filter paper followed by sterilization using 0.2 μm 
millipore filter, and the extracts were concentrated 
using rotavapor (Buchi, Switzerland) up to 40° C, and 
left at 4° C for 10 days to achieve complete dryness.  
Dry extracts were dissolved at 100 mg·mL-1 
using DMSO and water in the relation 1:24. These 
stock extract dilution were used in antimicrobial and 
antioxidant assays immediately or were stored at 4 °C 
for 14 days as a maximum. These stocks were diluted 
in culture medium (antimicrobial microdilution 
assay) or methanol (antioxidant assay). For the 
antimicrobial diffusion method, in order to 
standardize amount (mg) of extract by filter paper 
disk and considering that they are crude extract. Filter 
paper disks impregnated with 2 mg of plant extract 
were prepared in the following way: 20 µL (4 µL x 5 
times) of extracts were soaked in sterile filter paper 
disks of 5 mm and dried in a sterile chamber for 1 
hour. The amount of tetracycline, streptomycin or 
nystatin by each filter paper disk was 0.2 or 1.6 mg 
respectively, since they showed good inhibition halos 
between 10 - 25 mm against the strains tested.  
 
Antibacterial activity 
E. coli ATTC25922, S. aureus ATCC25923, B. 
subtilis ATCC11774, and P. aeruginosa ATCC27853 
were tested by diffusion and microdilution methods 
according to M02-A7 and M07-A8 protocols of the 
Clinical and Laboratory Standards Institute (CLSI).  
In both methods, the initial inoculum (IIB) 
was made with two colonies from a 14 hours grown 
plate diluted in NaCl 0.8% until 0.08 - 0.1 OD620. 
Streptomycin (Sigma) and tetracycline (Sigma) were 
used as standard antibiotics. Three replicates per test 
were performed, and the reproducibility was 
evaluated two times. 
 
Antibacterial diffusion assay 
The IIB was done by swabbing it twice onto 12 x 12 
cm Petri dishes (Sigma) containing 40 mL of Müller 
and Hinton Agar (MHA, Merck), and immediately 
filter paper disks soaked with a sample or standard 
antimicrobial solutions were placed on the inoculated 
Petri dishes. The sample disk contained 2 mg of 
sample or 0.2 mg of standard antibiotic. Plates were 
incubated for 24 hours at 35° C. The inhibition halos 
were measured subtracting the disk diameter; then 
values ≥ 2 were considered as inhibition. 
 
Antibacterial minimum inhibitory concentration 
(MIC) using tetrazolium salt 
Extracts were serial diluted in Müller and Hinton 
Broth II (MHBII, Difco) at 0.10, 0.25, 0.50, 0.75, 
1.00 to 10.00 mg·mL-1 (increasing 0.50). The serial 
dilutions were dispensed into 96-well plates (100 µL 
per well) and were inoculated with 10µL of IIBd (IIB 
diluted in MHBII 1:20). Controls of growth (MHBII 
with inoculum) and contamination (MHBII or 
extracts without inoculum) were prepared. Plates 
were incubated for 24 hours at 35° C. Tetrazolium 
salt was used as growth indicator (Ncube et al., 2008;  
Klančnik et al., 2010); adding 10 μL of tetrazolium 
violet 0.1% (TV, Sigma T0138) to each well and 
incubated for 4 hours at 35° C under dark. TV is 
reduced to violet precipitated, in presence of 
respiratory activity. MICs were considered like the 
lowest concentrations of extracts that inhibited the 
bacterial growth that was noticed by the absence of 
violet precipitated. 
 
Anti-Candida activity 
The susceptibility of C. albicans ATCC90028 was 
evaluated by diffusion and microdilution methods 
according to M44-A and M27-2A (CLSI) protocols 
with few modifications. Nystatin (commercial 
suspension) was used as an antifungal standard. 
Three replicates per test were performed and the 
reproducibility was evaluated two times. Preparation 
of initial inoculum (IIY) was similar to antibacterial 
assay. 
 
Anti-Candida diffusion assay 
IIY was done by swabbing it twice onto 12 x 12 cm 
Petri dishes with TSA and continued as described 
previously for the Antibacterial diffusion assay. 
Incubation was for 48 hours. The sample disk 
contained 2.0 mg, and the nystatin disk had 1.6 mg. 
 
Anti-Candida MIC using tetrazolium salt 
Extracts were serial diluted in TSB at 0.2, 0.5, 1.0, 
1.5, 2.0 to 20.0 mg·mL-1 (increasing 1.0). The serial 
dilutions were dispensed into 96-well plates (100 μL 
per well) and inoculated with 100 μL of IIYd (IIY 
diluted in TSB 1:5). Controls of growth and 
contamination were prepared. Plates were incubated 
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at 35° C for 48 hours, and MICs were obtained as 
described in Antibacterial minimum inhibitory 
concentration (MIC) assay. 
 
Antioxidant activity tested by DPPH scavenging 
method 
Microdilution method described by Guaratini et al. 
(2012) was used, and ascorbic acid was used as a 
standard. Extracts (100 mg·L-1) were serially diluted 
with methanol at 25 to 2000 μg·mL-1. 100 µl of each 
dilution was dispensed into six wells; immediately 10 
μL of fresh DPPH (10 mg·L-1 dissolved in MeOH) 
was added into three well, and 10 μL of MeOH into 
the other three. Plates were incubated at 25° C in 
darkness for 30 min. After, the absorbance at 517 nm 
was measured twice in a microplate 
spectrophotometer (BioTek, USA). The percentage of 
radical inhibition per sample was calculated as % I = 
[DPPHA - (MA-BMA)/DPPHA] x 100. Where 
DPPHA is the DPPH absorbance, MA is the 
absorbance of the sample plus DPPH, BMA is the 
absorbance of the sample without DPPH.  
The antioxidant activity was expressed as 
IC50, which represent the extract concentration to 
inhibit 50% of DPPH radical (Lee et al., 2003), and it 
is calculated from the regression curve I% versus 
extract concentration. 
 
Phytochemical evaluation 
Thin layer chromatography (TLC) and method 
proposed by Lock (1994) were used for 
phytochemical evaluation of samples leaf extracts 
that gave the best results. The evaluation was 
repeated twice and 250 mL of ethanol extracts 
prepared as previously described, were used. 
In the first method, 20 mL of ethanol extract 
were separated (fraction A), and 230 mL were dried 
and fractionated in 4 fractions (B, C, D, E) 
considering pH, solubility, and polarity (Lock, 1994). 
The presence of phenols, alkaloids, amino acids, 
tannins, triterpenes and/or steroids, 
leucoanthocyanidins, and quinones was evaluated 
with color reactions.  
TLC was developed on silica gel 60 F254, 
Aluminum sheets (Merck), with BAW (n-butanol-
acetic acid-water) at ratios (3:1:3), (4:1:1), (4:1:3) 
and (4:1:5). For the phenolic groups, the chromate 
plates were evaluated without or with FeCl3 (1%) or 
H2SO4 (1%) and were observed using white light, 
UV254, and UV365; the retention factor (Rf) of the 
separated compounds were calculated, color and 
fluorescence were observed and compared with 
literature (Wagner & Bladt, 1966; Harborne, 1984; 
Lock, 1994; Galand et al., 2002). Similarly, alkaloids 
were studied using Dragendorff reagent. 
 
Statistical analysis 
The antimicrobial and antioxidant assays were 
performed using 6 replicates, and phytochemical 
screening had 2 replicates. The results were 
expressed as values, and standard deviations were 
calculated. ANOVA and Duncan’s test were used to 
compare the values of antimicrobial diffusion assay 
and antioxidant DPPH scavenging method. 
 
Table No. 1 
Taxonomic, ethnopharmacology, market and endemism information of selected plants 
N° 
Scientific name, family, common 
names*/used part in popular medicine* 
Traditional medicinal use* 
CS** 
E
* M P 
1 
Alonsoa linearis (Jacq.) Ruiz & Pav. 
Scrophulariacea 
rirkacock, shoqumpa wëta, aturash, flor 
de muerto, pillwi pillwi, rinriqora, 
chanllillí ᶲ/whole plant 
To cure stomach pain. It is used with other plants to 
take baths against cold. (5, 6) 
x a  
2 
Baccharis genistelloides Pers. 
Asteraceae  
carqueja, kima esquina, cuchu-
cuchu/stem 
To cure urinary, liver, and kidney problems; to treat 
malaria, rheumatism, diabetes, and cholesterol. 
Diuretic, antidiarrheal, and blood purification.(5, 6, 7) 
x a  
3 
Berberis lutea Ruiz & Pavon  
Berberidaceae  
chekci, qarwash casha, qontsi, qarwa 
quinche, carhuascasa/fruit, root, leaf, 
stems 
As anti-inflammatory during respiratory tract, and 
muscle pains. It is used as dye: the fruit (color blue) 
and roots (color yellow). (4,6) 
   
4 
Buddleja incana Ruiz & Pav. 
Scrophulariacea 
To treat the Carrion disease (an endemic disease 
caused by Bartonella bacilliformis), it is an astringent 
x a  
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quisuar, quishuar/leaf to treat wart and to wash open sore. Leaf and barks 
are rubbed on genitals in order to prevent postpartum 
infections. It is used to take baths against cold. (4,5,6) 
5 
Gamochaeta americana (Mill) Wedd. 
Asteraceae  
alkupa allung, lengua de perro/leaf, 
stem, flowers 
 Against cold, conjunctivitis, and diarrhea. (5, 10) x w  
6 
Gentianella weberbaueri (Gild) Fabris  
Gentianacea 
puca makashqa, puca shaqwa, puca 
shaqapa, antenaria /whole plant 
To prevent cavities. The flowers are collected to 
decorate religious statues and the boiled extract is 
used as red coloring. (6) 
 fᴪ y 
7 
Hypericum laricifolium Juss. 
Hypericaceae 
chinchango, cypres, romero de la 
altura/stem, leaf, flower 
To cure warts, cold, chills, tiredness of all the body. 
Antidepressant. (5,6) 
x a  
8 
Jungia paniculata (DC.) A. Gray  
Asteraceae  
matico, qaramati, caramate/leaf 
For wound healing, injuries, stomach ulcers, 
nephritis, hemorrhoids, vaginitis, urinary tract illness 
and hurts. Antiseptic or antibiotic, and anti-
inflammatory. (4, 6, 8, 9) 
x a  
9 
Loricaria ferruginea (Ruiz & Pav.) 
Wedd. 
Asteraceae 
wallpapa chaquin, pata de gallo/stem 
To alleviate menstrual delay, and for blood 
circulation. Steam mixed up with other plants is used 
for bath to cold.  
(2, 5, 6) 
x a  
10 
Lupinus weberbaueri Lubr. 
Fabacea  
taulli macho, tararwa /leaf 
For stomach problems or ulcers, diabetes. The 
flowers are collected to decorate religious statues. (5) 
 fᴪ  
11 
Muehlenbeckia volcanica (Benth) Endl. 
Polygonaceae 
 mullaca , mullak´a, viruta, 
mullaka/whole plant, fruit 
For diarrhea, flu, asthma, other bronchia disorders, 
stomach pain and “internal wounds” with 
hemorrhage. Antipyretic, antitussive, analgesic and 
antiseptic to treat throat infections. (4,5, 8) 
x w  
12 
Notrotice obtusa A. W. Hill 
Malvacea  
raíz de alte, qori waqaq, shiric-yalckoy, 
tupucpa-ashuan/leaves, stem and flower 
Leaves and flowers of Notrotiche sp. are used to 
make a tea to treat colic. (6) 
To kidney problemsᶲ. 
x w y 
13 
Oenothera multicaulis Ruiz & Pavon 
Onagraceae  
chupasangre,tullpishᶲ/leaf 
Wound healing, and antiseptic. (9) x w  
14 
Oreocallis grandiflora (Lam.) R. Br.  
Proteacea 
tzaq'pa, chacpá, cucharillo/flowers, leaf, 
stem 
To alleviate flu and strong sensation of cold, cough, 
pain after hard work in the sun, headache, diabetes, 
and fever. To cure liver and kidney problems. (5,10) 
x f  
15 
Peperomia hartwegiana Miq. 
Piperacea  
congona redonda ᶲ, congona, 
winayquilla, congona /stem, leaf 
To cure gingivitis and otitis; lung, liver and kidney 
diseases, stomach ulcers, bruises. (5, 6) 
x a  
16 
Perezia coerulescens Wedd. 
Asteraceae 
valeriana, patza maki/root, rhizome 
To alleviate heart pain. Sedative, diuretic, and 
diaphoretic. 
(4, 5) 
x w  
17 
Perezia multiflora (Bonpl.) Less 
Asteraceae  
escorzunera, chancoruma/leaf 
Diuretic, febrifuge, sudorific, expectorant, 
antitussive, analgesic, anti-inflammatory. To treat 
back ache, stomach ache, flu, cough, bronchitis, 
tuberculosis, and diarrhea. To cicatrize teeth and 
throat injuries. (1, 4, 5, 6, 7) 
x w  
18 
Perezia pinnatifida (Bonpl.) Wedd. 
Asteraceae 
valeriana, contrahierba, valeriana 
fina/leaf, root, rhizome 
To treat asthmatic cough, headache, and heart 
disorders. Central nervous system stimulant, 
antitussive, sedative, tonic, tranquilizer. (4, 6) 
x w  
19 
Senecio calvus Cuatrec. 
Asteraceae 
Huamamrripa, vira vira/leaf 
For cough, respiratory sickness, and it is used in bath 
against cold. (4, 5) 
 
x w y 
20 Senecio canescens (Bonpl.) Cuatr. Sudorific, expectorant, antipyretic. To treat bronchia x w  
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Asteraceae 
ancosh, anqush, wila-wila, oreja de 
venado, utco, oreja de conejo/leaf 
disorders, flu, asthma, cough and cold. (2, 4, 6, 7, 8) 
21 
Senecio leucophorbius Cuatr. 
Asteraceae  
Used as S. canescens because it have similar 
morphology. (1) 
  y 
22 
Senecio rhizomatus Rusby 
Asteraceae  
llancahuasᶲ, llancahuasa/leaf 
For liver colic, and kidney infection. (4) x w  
23 
Senecio serratifolius (Meyen & Wapl.) 
Cuatrec. 
Asteraceae 
wamanripa /leaf, flowers 
For pneumonia. (6)    
24 
Valeriana henrici (Graebn.) B. Eriksen 
Caprifoliaceae 
corehuajay, qallu-qallu, llingli-llingli, 
rosetón/whole plant  
To alleviate heart pain, “mal aire”, and nauseas. (5,6) x w  
25 
Valeriana aff. pycnantha A. Gray. 
Caprifoliaceae 
Siete sabiosᶲ/whole plant  
To alleviate heart pain ᶲ x w  
26 
Valeriana globularis A. Gray. 
Caprifoliaceae 
Siete sabios/whole plant  
Its roots are eaten. (6) 
To alleviate heart painᶲ. 
x w  
27 
Werneria nubigena Kunth. 
Asteraceae 
yekishkoda, patzamaki/leaf, root 
For cold, and diarrhea. (5)    
28 
Xenophyllum dactylophyllum (Sch. Bip.) 
V.A. Funk 
Asteraceae 
cuncush, peqa-peqa, botón-botón/stem 
For head ache. It is used with other plants. (6) x a  
*, it was done with literature references: (1) Beltrán et al. (2006), (2) Bussman et al. (2010), (3) Ccana-
Ccapatinta et al. (2014), (4) De-la-Cruz et al. (2007), (5) Gonzales De La Cruz et al. (2014), (6) Kolff & Kolff 
(2005), (7) Monigatti et al. (2013), (8) Rehecho et al. (2011), (9) Rojas et al. (2003), (10) Tene et al. (2007). 
ᶲAuthor observation from Huaraz traditional markets. 
**, commercial status (CS) observed in traditional markets from Huaraz. M, observed in traditional markets 
from Huaraz: x, presence in traditional markets. P, part of the plant collected and marketed to diverse use: 
a, aerial part containing stem, leaves and flowers; f, only flower; w, whole plant; ᴪ, collected but not 
marketed. E, endemic from Peru: y, positive answer. 
 
Table No. 2 
Collection data of specimen plants selected 
N° Species Sample ID 
Collection 
Date 
Collection place 
Sector Latitude Longitude Elevation 
1 
Alonsoa linearis UNASAM
-HDS-127 
14/06/14 Qda. Quillcayhuanca -9.50447 -77.44772 3850m 
2 
Baccharis 
genistelloides 
UNASAM
-HDS-104 
10/06/13 Qda. Huaripampa -8.95068 -77.56283 3751 m 
3 
Berberis lutea UNASAM
-HDS-118 
29/09/13 Qda. Llanganuco -9.04832 -77.60837 3953 m 
4 
Buddleja incana UNASAM
-HDS-128 
22/09/13 Qda. Shallap -9.50106 -77.36886 4137 m 
5 
Gamochaeta 
americana 
UNASAM
-HDS-105 
14/05/15 Marketed    
6 
Gentianella 
weberbaueri 
UNASAM
-HDS-121 
23/01/13 Qda. Churup -9.47707 -77.42478 4570 m 
7 
Hypericum laricifolium UNASAM
-HDS-119 
15/06/14 Qda. Quillcayhuanca -9.50604 -77.44159 3861m 
8 
Jungia paniculata UNASAM
-HDS-106 
24/06/13 Road to Pitec, Huascaran 
National Park 
-9.51771 -77.48164 3392m 
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9 
Loricaria ferruginea UNASAM
-HDS-107 
29/09/13 Portachuelo from 
Llanganuco 
-9.04041 -77.57577 4403 m 
10 
Lupinus weberbaueri UNASAM
-HDS-120 
22/09/13 Qda. Shallap -9.49495 -77.36011 4246 m 
11 
Muehlenbeckia 
volcanica 
UNASAM
-HDS-125 
29/09/13 Portachuelo from 
Llanganuco 
-9.04492 -77.59792 4443 m 
12 
Nototriche obtusa UNASAM
-HDS-122 
10/06/13 Punta Unión, between Qda. 
Huaripampa-Santa Cruz 
-8.91228 -77.58159 4735 m 
13 
Oenothera multicaulis UNASAM
-HDS-123 
12/01/15 Aquia -10.0759 -77.14399 3409m 
14 
Oreocallis grandiflora UNASAM
-HDS-126 
30/09/13 Qda. Llanganuco -9.10854 -77.68562 3420m 
15 
Peperomia 
hartwegiana 
UNASAM
-HDS-124 
22/09/13 Qda. Shallap -9.50209 -77.37635 4128 m 
16 
Perezia coerulescens UNASAM
-HDS-108 
13/12/13 Qda. Churup -9.47619 -77.42422 4695 m 
17 
Perezia multiflora UNASAM
-HDS-109 
11/06/13 Path to Alpamayo, Qda. 
Santa Cruz 
-8.90928 -77.62427 4201 m 
18 
Perezia pinnatifida UNASAM
-HDS-110 
24/04/14 Marketed    
19 
Senecio calvus UNASAM
-HDS-111 
29/09/13 Portachuelo from 
Llanganuco 
-9.04641 -77.59298 4597 m 
20 
Senecio canescens UNASAM
-HDS-112 
10/06/13 Punta Unión, between Qda. 
Huaripampa-Santa Cruz 
-8.91228 -77.58159 4735 m 
21 
Senecio leucophorbius UNASAM
-HDS-113 
11/06/13 Path to Alpamayo, Qda. 
Santa Cruz 
-8.89591 -77.63219 4293 m 
22 
Senecio rhizomatus UNASAM
-HDS-114 
29/09/13 Portachuelo from 
Llanganuco 
-9.04041 -77.57577 4403 m 
23 
Senecio serratifolius UNASAM
-HDS-115 
05/01/13 Qda. Ulta -9.12989 -77.51445 4864 m 
24 
Valeriana aff. 
pycnantha 
UNASAM
-HDS-130 
13/12/13 Qda. Churup -9.47650 -77.42436 4680 m 
25 
Valeriana globularis UNASAM
-HDS-131 
27/05/16 Marketed    
26 
Valeriana henrici UNASAM
-HDS-129 
27/01/16 Marketed    
27 
Werneria nubigena UNASAM
-HDS-117 
10/06/13 Qda. Huaripampa -8.95067 -77.56283 3751 m 
28 
Xenophyllum 
dactylophyllum 
UNASAM
-HDS-116 
10/06/13 Punta Unión, between Qda. 
Huaripampa-Santa Cruz 
-8.91228 -77.58159 4735 m 
Qda. quebrada. Collectors were C.Tamariz & P. Olivera 
 
 
 
 
RESULTS 
Plant material 
According to the ethnopharmacology information 
twenty-eight plants of twelve families were selected. 
Then, twenty four were collected and four were 
bought at Challhua, a popular market from Huaraz 
(Tables No. 1 & 2 and Figure No. 1). Most species 
are used for flu, some for urinary diseases, dental 
cleaning, wounds or stomach pain. A few are used for 
diseases related to oxidative stress such as diabetes, 
heart pain or nerves. From observation in traditional 
markets from Huaraz, thirteen species are marketed 
as whole plant, from which P. coerulescens, P. 
pinnatifida, N. obtusa, V. henrici, V. aff. pycnantha 
are considered highly vulnerable because they are 
collected with lots of flowers and sailwomen refer 
that they are collected from places near the glaciers. 
About endemisms, four plants are endemic (Table 
No. 1). Additional, the flowers of G. weberbaueri, L. 
weberbaueri, and O. grandiflora are used as 
ornamental. This last one is marketed, and other two 
are used to decorate statues in Holy week. 
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Figure No. 1 
Map of the collection area. Numbers are the samples are in the Table No. 2 
 
 
Antibacterial activity 
The size of the clear zone of growth inhibition (halo) 
and MICs are shown in Table No. 3. Two plants (M. 
volcanica and O. grandiflora) showed activity 
against the four bacteria tested, three against three 
bacteria (H. laricifolium, L. ferruginea, and O. 
multicaulis), 17 plants against two bacteria, three 
against one bacterium tested, and only one plant did 
not show activity.  
In the diffusion test against S. aureus, the 
statistic test showed that 2 mg·L-1 ethanolic extracts 
activity of B. incana, G. americana, A. linearis, O. 
multicaulis, O. grandiflora did not have a significant 
difference with 0.2 mg·L-1 streptomycin, it means that 
these extracts have the same activity that streptomicin 
at the condition descripted. In this way, the activity of 
P. hartweguiana (2 mg·L-1) against B. subtilis did not 
show a statistic difference with tetracycline (0.2 
mg·L-1), this activity was followed by S. rhizomatus, 
O. multicaulis, L. ferruginea, and others.  
It was found that positive results in the 
diffusion test were also positive in the dilution 
method with exception of a few extracts (7, 11, 14), 
and this could be related to the bioactive metabolite 
solubility involved in the antibacterial effect. Then, 
considering the two methods, three (9, 11, 14) and 
four (7, 11, 13, 14) plants had antibacterial activities 
against E. coli, and P. aeruginosa respectively. In the 
disk diffusion assay against E. coli only two (9, 14) 
extracts were positive, but their activities was low 
compared to standard antibiotics used. Interestingly, 
2 mg·L-1 of O. grandiflora extract showed better 
inhibition halo than 0.2 mg·L-1 tetracycline against P. 
aeruginosa.  
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Finally, according to diffusion assay, low 
MICs and/or a broad spectrum of antibacterial 
activity were found for H. laricifolium, L. ferruginea, 
O. grandiflora, M. volcanica, and O. multicaulis. 
Anti-Candida activity 
The antifungal activity against C. albicans was 
uncommon in the plants tested; only G. weberbaueri, 
L. ferruginea, and O. multicaulis showed anti-
Candida activities using the dilution and diffusion 
methods, while X. dactylophyllum had a slightly 
positive activity with the diffusion method (Table No. 
3). 
 
Antioxidant activity 
Table No. 3 shows the IC50 of antioxidant activity 
using DPPH scavenging assay, values and the 
statistic test was made only to samples which showed 
IC50 less than 300 µg·L-1; values ≥ 300 µg·L-1 are not 
reported. The lowest IC50 values were found in leaves 
and stems of H. laricifolium (55.6 ± 2.4 and 62.3 ± 
2.0 µg·L-1), and leaves of G. americana (65.4 ± 12.1 
µg·L-1); followed for M. volcanica (98.7 ± 3.1 µg·L-1) 
and leaves of O. grandiflora (113.5 ± 4.4 µg·L-1). 
These plants are considered promissory to continue 
research. 
 
Phytochemical evaluation 
In concordance to the antimicrobial and antioxidant 
results, O. grandiflora, H. laricifolium, G. 
weberbaueri, G. americana, L. ferruginea, M. 
volcanica, and O. multicaulis were selected for 
phytochemical evaluation. Following Lock (1994) 
method, the tannins were present in the majority of 
plants, flavonoids and leucoanthocyanidins were also 
abundant. Alkaloids were found in five plants, 
triterpenes and/or steroids in four, amino acids in 
three, and quinones only in one (Table No. 4). In the 
TLC method, BAW (4:1:5) was the best mobile 
phase and was selected to all assays. According to the  
different retention factor (Rf), color and fluorescence 
of the different TLC treatments with or without  
FeCl3 or H2SO4 for phenolic compounds and 
Dragendorf for alkaloids; it was possible to 
differentiate some types of tannins, flavonoids, 
alkaloids and other phenolic compounds for each 
sample (Table No. 5). Both methods assayed were 
complementary, and did not show contradictory 
results. 
DISCUSION 
Most of plants selected (96%) showed antibacterial 
activity at least against one bacterial strain tested 
supporting the importance and usefulness of the 
ethnobotanical information about plants that cure 
infection during research of new antimicrobial 
compounds. The anti-Candida activity is consider as 
an urgent need to explore in active constituents of 
traditional medicine, because candidiasis of the skin, 
nails, oral cavity, esophagus and vagina is the most 
prevalent fungal infection; (Tangarife-Castaño et al., 
2011; Zida et al., 2017) and four plants (14%) 
showed this activity; correlation with their traditional 
uses are discussed below. On the other hand, four 
species (5, 7, 11, 14) showed promising antioxidant 
activity; this activity could be helpful in the case of 
diseases caused by oxidative stress such as cancer, 
diabetes, and neurodegenerative problems (Tauchen 
et al., 2016) but other assays to confirm this activity 
could be necessary. Although most of the plants 
showed antimicrobial activities, the discussion is 
focusing mainly in the plants with promising results.  
 
Table No. 3 
Antimicrobial and antioxidant activities of ethanolic extracts of medicinal plants 
N° Species PE 
Antimicrobial activity 
Diameter inhibition halo* mm, (MIC mg·mL-1) 
DPPH activity 
IC50 
µg·L-1 Sa Bs Ec Pa Ca 
1 
A. linearis 
 
l 
15.5 ± 2.1bcd 
(2.5) 
5.5±0.7ef 
(2.5)    
274.2 ± 17.0g 
s 
8.5±0.7gh 
(3.0) 
4.5±2.1efgh 
(3.0)     
2 
B. genistelloides 
 
s 
4.5±0.7ijkl 
(4.0) 
3.5±0.7efgh 
(4.0) 
 
   
3 
B. lutea 
 
l 
7.0±1.4hi 
(7.5) 
3.5±0.7efgh 
(5.0)    
202.2 ± 8.5d 
4 
B. incana 
 
l 
16.5±0.7bc 
(3.0) 
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5 
G. americana 
 
l 
15.5±0.7bcd 
(2.5) 
2.5±0.7gh 
(3.5) 
 
  
65.4 ± 12.1b 
6 
G. weberbaueri 
 
l 
6.0±1.4hijk 
(3.0) 
4.0±1.4efgh 
(3.0)   
3.0±0.0d 
(8.0) 
236.4 ± 1.9fg 
r 
6.5±0.7hij 
(2,5) 
4.5±2.1efgh 
(3.0)   
8.0±0.0bc 
(5.0) 
282.6 ± 15.9e 
7 
H. laricifolium  
 
l 
8.5±0.7gh 
(0.5) 
4.0±1.4efgh 
(0.5)  
0.0 
(8.0)  
55.6 ± 2.4b 
s 
7.0±1.4hi 
(0.4) 
5.0±1.4efg 
(1.0)  
0.0 
(8.0)  
62.3 ±  2.0b 
8 
J. paniculata 
 
l 
6.0±2.8hijk 
(3.0) 
2.5±0.7gh 
(9.0) 
 
   
9 
L. ferruginea 
 
l+s 
13.5±0.7cdef 
(2.5) 
6.0±1.4e 
(3.0) 
3.5±0.7d 
(>10)  
8.0±0.0bc 
(8.0)  
10 
L. weberbaueri 
 
l   
    
11 
M. volcanica 
 
l+s 
3.0±0.0ijkl 
(2.0) 
0.0 
(3.0) 
0.0(8.0) 
7.0±0.0d 
(8.0)  
98.7 ± 3.1c 
12 
N. obtusa  
 
l 
3.5±0.7ijkl 
(7.5) 
4.5±2.1efgh 
(3.0)     
s 
1.5±0.7l 
(>10.0) 
3.5±0.7efgh 
(5.0)     
13 
O. multicaulis  
 
l 
15.0±2.8bcde 
(2.0) 
9.5±0.7d 
(1.5)  
0.0 
(8.50) 
8.0±1bc 
(1.0)  
r 
4.0±1.4ijkl 
(2.0) 
9.5±0.7d 
(5.5)  
4.0±0.7d 
(9.0) 
7.0±1c (1.5) 
 
14 
O. grandiflora  
 
l 
15.0±1.4bcde 
(1.5) 
2.5±0.7gh 
(2.5) 
5.0±0.0c 
(8.0) 
15.0±1.4b 
(1.5)  
113.5 ± 4.4c 
15 
P. hartwegiana 
 
l+s 
7.0±0.0hi 
(2.0) 
16.5±0.7bc 
(3.0)     
16 
P. coerulescens 
 
l 
2.5±0.7kl 
(>10) 
4.5±0.7efjh 
(5.5) 
 
   
rh+ 
r 
6.5±0.7hij 
(>10) 
4.5±0.7efgh 
(3.0) 
 
   
17 
P. multiflora 
 
l 
 
2.5±0.7gh 
(7.0)     
18 
P. pinnatifida 
 
rh+ 
r 
2.5±0.7kl 
(>10) 
4.5±0.7efgh 
(3.0)     
19 
S. calvus 
 
l 
12.0±2.8ef 
(5.0) 
2.0±0.0h 
(>10)     
20 
S. canescens 
 
l 
5.5±2.1hijk 
(5.0) 
0.0 
(8.0)     
21 
S. leucophorbius 
 
l 
11.0±2.8fg 
(>10)      
22 S. rhizomatus  l 
4.5±0.7ijkl 
(>5.0) 
14.5±0.7c 
(3.0)     
23 
S. serratifolius 
 
l 
4.5±2.1ijkl 
(8.5) 
0.0 
(8.0)     
24 
V. henrici 
 
l+r 
 
0.0 
(8.0)     
25 
V. aff. pycnantha 
 
l+r 
6.5±2.1hij 
(3.0) 
3.0±0.0fgh 
(1.5)     
26 
V. globularis 
 
l 
6.0±1.4hijk 
(5.5) 
0.0 
(3.0)     
27 
W. nubigena 
 
l+r 
3.0±0.0jkl 
(4.0) 
3.0±0.0fgh 
(6.0)     
28 
X. dactylophyllum 
 
l+s 
12.5±2.1def 
(2.0) 
4.5±0.7efgh 
(2.0)   
9.0±1.0b 
(>10)  
         
 Tetracycline  
 
20,0±1,4ab 18.5±2.1b 15.5±0.7b 13.0±0.0c 
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(<0.02) (<0.02) (<0.02) (<0.02) 
 Streptomycin 
 
17,5±0,7a 
(<0.02) 
25.5±0.7a 
(<0.02) 
20.0±0.0a 
(<0.02) 
17.5±0.7a 
(<0.02)   
 Nystatin 
     
11.0±1.4a 
(>1.0)  
 Ascorbic acid       22.6  ± 0.3a 
PE, part of plant used to prepare the extract; l, leaf; s, stem; r, root; rh, rhizome; f, flower; w, whole plant. 
Sa, S. aureus; Bs, B. subtilis; Ec, E. coli; Pa, P. aueriginosa; Ca, C. albicans. 
*, inhibition halo was calculated minus 5 mm (filter paper disk). 
Values ± standard deviation, and letters as super index correspond to statistic group according to Duncan’s 
test (p<0.05). 
 
Table No. 4 
Phytochemical composition using Lock (1994) method 
Type of secondary 
metabolite 
Color reagent  
Plants 
Ogl Hll Gwl Gal Lfa Mva Oml 
Alkaloid Dragendorff Mayer x x x x x     
Tannin Gelatin x x   x x x x 
Phenolic compound FeCl3 x x x x x x x 
Flavonoid Shinoda x x x x     x 
Leucoanthocyanin Rosenheim        x x x   
Triterpen and/or steroid Lieberman-Buchard   x x     x x 
Quinone  Bortranger              x 
Og, O. grandiflora; Hl, H. laricifolium; Gw, G. weberbaueri; Ga, G. americana; Lf, L. ferruginea; Mv, M. 
volcanica; and Om, O. multicaulis. l, leaves; a, whole aerial part.“x” represent the presence of the secondary 
metabolite 
 
H. laricifolium is a shrub that grows in the 
high Andean areas from Venezuela, Ecuador, and 
Peru (Crockett et al., 2010). Some Hypericum species 
are well known for their medicinal properties (Cirak 
et al., 2017), and H. laricifolium is used mainly to 
treat cold, wart, and as an antidepressant (Table No. 
1). Their leaves and stems showed activities against 
P. aeruginosa, B. subtilis, and S. aureus. The latter  
activity was also reported for ethanolic, methanolic 
and chloroformic extracts of samples from other 
regions (Bussmann et. al., 2010; Jerves-Andrade et 
al., 2014). Antibacterial compounds of H. 
laricifolium have not still been determined; but 
tetraketone and hyperforin were isolated from H. 
perfolatum had antibacterial and antidepressant 
activities (Saddiqe et al., 2010). Some Hypericum 
species are known for their antioxidant property 
(Kızıl et al., 2008; Boga et al., 2016), and H. 
laricifolium showed antioxidant activity with DPPH 
assay. In their phytochemistry, Hypericum species 
contain phenolic, flavonoids and tannins compounds, 
which would be responsible for their cytotoxic, 
antitumor, and anti-inflammatory properties (Boga et 
al., 2016); in concordance, H. laricifolium has 
phenolic compounds especially flavonoids and gallic 
tannins. Likewise, its leaves contain caffeic acid (El-
Seedi et al., 2003) which is a potent antioxidant 
(Gülçin, 2006); acylphloroglucinol derivatives 
(Ccana-Ccapatinta & von Poser, 2015) which are 
associated with antitumor, antibacterial, and anti-HIV 
activities of H. sampsonii (Zhu et al., 2015). Also, H. 
laricifolium inhibited a proliferative growth of Hep3 
cells (Carraz et al., 2015), but the compounds 
involved in this effect are not described yet.  
O. grandiflora is a tree that grows in the 
Peruvian inter-Andean valleys between 1500-4000 
m.a.s.l. (Reynel & Marcelo, 2009), and some areas 
from Ecuador (Alejandro-Espinosa et al., 2013). It is 
used to treat cold and fever (Tene et al., 2007; 
Gonzales De La Cruz et al., 2014); and it has shown 
a broad spectrum of antibacterial activity, where the 
halos size against S. aureus and P. aeruginosa were 
similar to reference antibiotic halos. Likewise, O. 
grandiflora has shown antioxidant activity, possibly 
by the presence of phenolic compounds such as 
catecholic tannins and flavonoids found in its 
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phytochemical evaluation. It is used to treat diabetes 
(Gonzales De La Cruz et al., 2014), which could be 
related to its antioxidant activity; however, 
Alejandro-Espinosa et al. (2013) have found that O. 
grandiflora leaves inhibited α-amylase and β-
glucosidase as a hypoglycemic activity mechanisms, 
and showed antioxidant activity using DPPH assay. 
About its conservation status, Pretell et al. (1985) 
consider that O. grandiflora is an endangered species 
in Peru due to its irrational use; besides it is being 
displaced from its habit by exotic and agricultural 
forest species; thus, Olivera-Gonzales et al. (2017a) 
have performed a methodology for O. grandiflora in 
vitro propagation such as an alternative for its 
conservation. 
 
 
Table No. 5 
Phytochemical evaluation using TLC with reagent and detection method 
Plant Alkaloid Type of tannins Type of flavonoid (number) 
Other phenolic 
compound 
Ogl 2 catechol (1) 
flavanonol,  flavone, flavonone or isoflavone 
(3); anthocyanin (1) 
 2 
Hll 3 catechol (3) flavone, isoflavone or  flavonol (6)    4 
Gwl 2 - flavone, isoflavone or flavonol (5)   2 
Gal 2 catechol (2) flavanone or flavone (2) 4 
Lfa 3 catechol (1) flavanone or flavone (2) 6 
Mva 3 catechol (1) flavone, flavonol or flavanone (3) 4 
Oml 1 gallic acid (1) flavonol, flavone or chalcone (2) 1 
Og, O. grandiflora; Hl, H. laricifolium; Gw, G. weberbaueri; Ga, G. americana; Lf, L. ferruginea; Mv, M. 
volcanica, and Om, O. multicaulis. l, leaves; a, whole aerial part. 
 
 
G. weberbaueri is a herb that is an endemic 
plant from Ancash (Peru) that grows between 3900 to 
5100 m a. s. l., and it is in vulnerable status (Castillo 
et al., 2006). It is used to avoid cavities (Kolff & 
Kolff, 2005), and we observed antimicrobial activity 
against S. aureus, B. subtilis, and C. albicans, 
remarking that C. albicans is a yeast involved in 
dental infections (de Oliveira et al., 2013). No other 
medicinal uses have been reported, interestingly G. 
weberbaueri has shown antioxidant activity. Other 
Gentianella species are used to treat diabetic, liver 
and depurative disorders (Li et al., 2010; Gonzales de 
la Cruz et al., 2014); and according to the 
phytochemical and ethnopharmacology review of 
Gentianella this genus is considered as a great source 
of medicinal plants characterized by the presence of 
xanthones, C-glucoflavonoids, and terpenoids, which 
are probably responsible for their biological activity 
(Li et al., 2010). The phytochemical evaluation has 
found alkaloids, phenolic compounds, flavonoids, 
and triterpenes and/or steroids in its leaves, but 
studies about this plant are scarce. 
G. americana is a herb with a wide 
distribution in Central and South America; in Peru, it 
grows in different habitats (Dillon & Sagástegui, 
1991) mainly as weed. In traditional medicine, it is 
used as an antiseptic and for this reason is named 
commonly "alkupa allung", which means "dog's 
tongue"; it is also used to alleviate diarrhea (Gonzales 
De La Cruz et al., 2014). In agreement with previous 
ethnopharmacology studies, G. americana showed 
good antibacterial activity against B. subtilis and S. 
aureus, being the last a common pathogen of purulent 
infections (Lima et al., 2016). Both bacteria could be 
involved in diarrheal processes. Although G. 
americana is not used for chronic diseases, it showed 
good antioxidant activity (IC50 65.4 ± 12.1 µg·L-1). 
The phytochemical evaluation revealed the presence 
of alkaloids, tannins, catechol, flavonoids and 
phenolic compounds.  
M. volcanica grows between 1500 - 4500 
m.a.s.l. from Mexico to Bolivia (Heim, 2014). It 
showed broad activity against gram positive and 
negative bacteria, which could be in agreement with 
its traditional use as antiseptic and anti-diarrheal 
(Rehecho et al., 2011). It also showed good 
antioxidant activity and could be due to the presence 
of phenolic compounds such as catechol. Despite its 
wide distribution, it has been categorized as 
endangered species in Canta - a Peruvian Andean 
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province - because it is highly collected without agro-
ecological study for its conservation and sustainable 
use (De-la-Cruz et al., 2007).  
O. multicualis inhibited the growth of B. 
subtilis, S. aureus, P. aeruginosa, and C. albicans, 
such as reported Rojas et al. (2003). Furthermore, the 
last three bacteria are related to skin infections (Lima 
et al., 2016), which could explain its usefulness as an 
antiseptic (Table No 1). O. multicaulis has shown the 
presence of tannins, phenolic compounds, flavonoids, 
triterpenes and/or steroids, quinones and amino acids; 
with exception of the two last compounds all were 
described in other Oenothera species (Festa et al., 
2015). Likewise Srivastava et al. (2007) isolated 
oenosyticin - a potent metabolite against S. aureus 
and S. epidermidis - from O. biennis; but no more 
phytochemical research was found for the family. O. 
multicualis is widely distributed from Ecuador to 
Bolivia; however, the whole plant is collected 
identifying it as a probably threatened species.  
L. ferruginea is a shrub that grows from 
Central Ecuador - Central Peru between 3300-4800 
masl, and is sold as a medicinal plant in popular 
markets (Dillon & Sagastegui, 1991). It is used 
together to others plants for bathing (Gonzales de la 
Cruz et al., 2014). It showed antibacterial activity 
against S. aureus, B. subtilis, and E. coli; as well as 
anti-Candida activity. Concerning its phytochemical 
composition, phenolic compounds and catechol-type 
tannins were found. Malca et al. (2016), reported the 
presence of 5,7-dimethoxycoumarin that inhibit 
cancer cells and 5,7,8-trimethoxycoumarin with anti-
HIV activity, being the only other publication 
describing the phytochemical content of this plant  
In addition, ethanolic extracts from others 
species such as A. linearis, B. incana, J. paniculata, 
P. hartwegiana, V. aff. pycnantha, and X. 
dactylophyllum showed MICs up to 3.0 mg·mL-1 
against S. aureus; this activity could be important 
because S. aureus is one of the main opportunistic 
pathogens with high capacity to acquire resistance to 
chemotherapy (Mendem et al., 2016); likewise, other 
plants are still important because it is possible that 
they have other medicinal properties, e.i. P. 
coerulescens and P. muliflora have shown an 
antiproliferative activity of Hep3B hepatocarcinoma 
cells (Carraz et al., 2015). 
 
CONCLUSION 
This is the first study that focuses on completely wild 
native plants from the Peruvian high Andes, a fragile 
ecosystem facing global warming; and according to 
these results the most promising species are G. 
americana, G. weberbaueri, H. laricifolium, L. 
ferruginea, M. volcanica, O. multicaulis and O. 
grandiflora. There is enough evidence about their 
pharmacological potential as an important source for 
new drugs. Most of the plants do not have 
phytochemical and bioactive activity information and 
in many cases, the whole plants are collected without 
management plans and are over exploited. For this 
reason, their promising biological activities studies 
and biotechnological applications could contribute to 
improve their conservation and sustainable use.  
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